Back to Top
Tafasitamab Biosimilar - Research Grade
Tafasitamab Biosimilar - Research Grade
Product Benefits:ichorbio’s Tafasitamab Biosimilar for Research Use Only (RUO)
Target:CD19
Size:ichorbio’s Tafasitamab Biosimilar is available in the following sizes: 1mg, 5mg, 10mg, 20mg, 50mg
Isotype:Human IgG1(S239D/K274Q/Y296F/Y300F/L309V/I332E/A339T/V397M)-Kappa
Host:CHO Cells
Species Reactivity:Human
Specificity:Detects human CD19.
Purification Method:This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Concentration:
5mg/ml
Formulation:Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purity:>95% by SDS-PAGE
Endotoxin:≤ 1.0 EU/mg as determined by the LAL method
Storage:This antibody is stable for at least 4 weeks when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at – 20°C or -80°C. Avoid repeated freeze thaw cycles.
Applications:Functional Assays
Application Notes:This biosimilar is strictly for research use only (RUO).
| Concentration | 5.69mg/ml |
|---|---|
| isotype | Human IgG1(S239D/K274Q/Y296F/Y300F/L309V/I332E/A339T/V397M)-Kappa |
| Host | CHO Cells |
Write Your Own Review
Who Viewed This Also Viewed
